News

3 Sep 2009

LinkMed's portfolio company Likvor has been granted CE marking for its instrument for better and safer identification and diagnosis of Normal Pressure Hydrocephalus (NPH). The instrument, CELDA®, was developed to assess the dynamics - pressure, flow and resistance - of cerebrospinal fluid (CSF) surrounding the brain and spinal cord. CELDA® facilities greater understanding and enhanced diagnosis of NPH, a condition that is often mistaken for dementia. CE marking opens up the European market for the product.

Pages